Clinical Trial Update: Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating CLBS12 for critical limb ischemia has completed. The update covers the trial status in patients with related vascular conditions such a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis Obliterans
• Critical Limb Ischemia
• Thromboangiitis Obliterans

Drugs mentioned

• CLBS12

Snippet

Sponsor: Lisata Therapeutics, Inc. | Conditions: Critical Limb Ischemia, Buerger Disease | Phase 2 | Status: COMPLETED